Overview

Cardiac arrhythmia monitoring Market Introduction:

Cardiac arrhythmia monitoring devices market is estimated to value over USD 8.5 billion by 2027 end with a CAGR of 7% during the forecast period of 2020-2027. 

Cardiac arrhythmia monitoring refers to the identification of type and cause of irregular heart rhythms in a person's heartbeat. Cardiac arrhythmias are caused due to an abnormality in the heart’s electrical system which is responsible for the formation of the electrical impulse. Cardiac rhythms are monitored using electrocardiography (ECG) & electrophysiology devices. 

This market study covers market value forecast of various type of electrocardiography (ECG) & electrophysiology devices used across end-user settings such as Hospitals, Clinics, Diagnostic Laboratories, Long Term Care Centres, Homecare Settings, Ambulatory Surgical Centres, Cath Labs, & Emergency Medical Services. 

Cardiac Arrhythmia Monitoring Devices Market Key Findings:

• ECG Testing Devices segments in market are expected to grow at a CAGR of 5.4% during the forecast period
• Implantable Cardiac Monitoring Devices & ECG Testing Devices in  market are collectively accounted for US$ 4,035.8 Mn in 2018 and is expected to reach US$ 6,204.8 Mn by the end of 2026.
• Hospitals segments in market exhibits US$ 628 over 2018-2026
• Clinics segments are expected to exhibit incremental opportunity of US$ 522 Mn over 2018-2026
• Asia Pacific market is expected to grow at a CAGR of 6.5% during the forecast period

Cardiac Arrhythmia Monitoring Devices Market Landscape: 

Medtronic plc., NUUBO Smart Solutions Technologies, SL, Koninklijke Philips N.V., GE Healthcare, Welch Allyn – A Hill-Rom Inc. Company, Nihon Kohden Corporation, Biotelemetry, Inc., Biotronik, Inc., Abbott Laboratories,Spacelabs Healthcare.  

Cardiac Arrhythmia Monitoring Devices Market Segmentation:

By Product 

• Implantable Cardiac Monitoring Devices 
• ECG Testing Devices 
• Mobile Cardiac Telemetry Monitors 
• Event Recorder

By Application 

• Artery Disease 
• Arrhythmia 
• Coronary
• Hypertension

By End User

• Hospitals 
• Clinics 
• Diagnostic Laboratories 
• Long Term Care Centres 
• Homecare Settings 
• Ambulatory Surgical Centres 
• Cath Labs 
• Emergency Medical Services

By Region

• Europe  
• North America  
• APAC  
• Latin America
• Rest of World

Competitive Landscape:  

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players 
• Emerging players which are growing rapidly 
• New Entrants  

FutureWise Takeaways:  

• Growth prospects  
• SWOT analysis 
• Key trends 
• Key data-points affecting market growth  

Objectives of the Study:

• To provide with an exhaustive analysis on global cardiac arrhythmia monitoring devices market by product type, application, end user, and region 
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market  
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East 
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions 
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies  

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
         1.1 Objectives of the Study 
         1.2 Market Definition 
         1.3 Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
         1.4 Currency   
         1.5 Limitations 
         1.6 Stakeholders 
 2. Research Methodology 
         2.1 Research Data 
                 2.1.1 Secondary Data
                           2.1.1.1 Key Data From Secondary Sources
                 2.1.2 Primary Data
                           2.1.2.1 Key Data From Primary Sources
        2.2 Market Size Estimation 
        2.3 Market Breakdown and Data Triangulation 
        2.4 Assumptions for the Study
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Global Cardiac Arrhythmia Monitoring Devices Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Market Overview
       5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Cardiac Arrhythmia Monitoring Devices Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Cardiac Arrhythmia Monitoring Devices Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
           7.1. Implantable Cardiac Monitoring Devices
           7.2. ECG Testing Devices
           7.3. Mobile Cardiac Telemetry Monitors
           7.4. Event Recorder
8. Global Cardiac Arrhythmia Monitoring Devices Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
           8.1. Artery Disease
           8.2. Arrhythmia
           8.3. Coronary
           8.4. Hypertension
9. Global Cardiac Arrhythmia Monitoring Devices Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
           9.1. Hospitals
           9.2. Clinics
           9.3. Diagnostic Laboratories
           9.4. Long Term Care Centres
           9.5. Homecare Settings
           9.6. Ambulatory Surgical Centres
           9.7. Cath Labs
           9.8. Emergency Medical Services
10.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs
        10.1. Introduction
        10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            10.2.1. U.S.A
            10.2.2. Canada
            10.2.3. Mexico
        10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       11.1. Introduction
       11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           11.2.1. Germany
           11.2.2. U.K
           11.2.3. France
           11.2.4. Italy
           11.2.5. Spain
           11.2.6. Russia
           11.2.7. Poland
           11.2.8. Switzerland
           11.2.9. Rest of Western Europe
12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 
             12.2.1. Japan
             12.2.2. China
             12.2.3. Singapore
             12.2.4. India
             12.2.5. Australia and New Zealand
             12.2.6. ASEAN
             12.2.7. South Korea
             12.2.8. Rest of Asia Pacific
        12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 
        13.1. Introduction
        13.2. Regional Market Trends
        13.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019

            13.3.1. Brazil
            13.3.2. Venezuela
            13.3.3. Argentina
            13.3.4. Rest of Latin America

        13.4. Market Size (USD Million) Forecast for Latin America 2020-2027
14. Rest of World Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
               14.2.1. Saudi Arabia
             14.2.2. UAE
             14.2.3. South Africa
             14.2.4. Egypt
14.3. Market Size (USD Million) Forecast for MEA 2020-2027

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         15.1. Medtronic plc.
                15.1.1. Company Overview
                15.1.2. Product Portfolio
                15.1.3. SWOT Analysis
                15.1.4. Financial Overview
                15.1.5. Strategic Overview
         15.2. NUUBO Smart Solutions Technologies SL
                15.2.1. Company Overview
                15.2.2. Product Portfolio
                15.2.3. SWOT Analysis
                15.2.4. Financial Overview
                15.2.5. Strategic Overview
         15.3. Koninklijke Philips N.V.
                15.3.1. Company Overview
                15.3.2. Product Portfolio
                15.3.3. SWOT Analysis
                15.3.4. Financial Overview
                15.3.5. Strategic Overview
         15.4. GE Healthcare
                15.4.1. Company Overview
                15.4.2. Product Portfolio
                15.4.3. SWOT Analysis
                15.4.4. Financial Overview
                15.4.5. Strategic Overview
         15.5. Welch Allyn – A Hill-Rom Inc. Company
                15.5.1. Company Overview
                15.5.2. Product Portfolio
                15.5.3. SWOT Analysis
                15.5.4. Financial Overview
                15.5.5. Strategic Overview
         15.6. Nihon Kohden Corporation
                15.6.1. Company Overview
                15.6.2. Product Portfolio
                15.6.3.  SWOT Analysis
                15.6.4. Financial Overview
                15.6.5. Strategic Overview
         15.7. Biotelemetry, Inc.
                15.7.1. Company Overview
                15.7.2. Product Portfolio
                15.7.3. SWOT Analysis
                15.7.4. Financial Overview
                15.7.5. Strategic Overview
         15.8. Biotronik, Inc.
                15.8.1. Company Overview
                15.8.2. Product Portfolio
                15.8.3. SWOT Analysis
                15.8.4. Financial Overview
                15.8.5. Strategic Overview
         15.9. Abbott Laboratories
                15.9.1. Company Overview
                15.9.2. Product Portfolio
                15.9.3. SWOT Analysis
                15.9.4. Financial Overview
                15.9.5. Strategic Overview
         15.10. Spacelabs Healthcare
                15.10.1. Company Overview
                15.10.2. Product Portfolio
                15.10.3. SWOT Analysis
                15.10.4. Financial Overview
                15.10.5. Strategic Overview
16. FutureWise SME key takeaway points for Client

Tables

Figures